Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:21 PM
What would change this read
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)Convexia | Smarter Drug Sourcing Starts Here Discover reliable and smarter drug sourcing solutions for your needs.
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jun 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jun 2025). Investors: Y Combinator. (High).
Product / news
1 product/news‑styled row(s); headline risk without filings (High).
Verified facts
Summer 2025 batch; AI-maximalist pharma sourcing and diligence.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:21 PM · confidence 88%high quality
wikipedia · Mon, Jun 29, 01:42 AM · confidence 50%medium quality
Wed, May 20, 06:21 PM · confidence 85%medium quality
Newest first · 7 event(s)
Source: Homepage
Discover reliable and smarter drug sourcing solutions for your needs.
Source: official_site
Convexia | Smarter Drug Sourcing Starts Here Overview ConvexiaBench Tech Stack FAQ Contact Login → Login → Uncover Drug Assets 10x faster Find and evaluate drugs better than ever before. Test the Agents Free to try. No credit card. Overview How Convexia Works…
AI-driven drug sourcing and diligence for pharma.
Summer 2025 batch; AI-maximalist pharma sourcing and diligence.
Agents surface shelved and overlooked preclinical assets.
3 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
Discover reliable and smarter drug sourcing solutions for your needs.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Convexia | Smarter Drug Sourcing Starts Here Overview ConvexiaBench Tech Stack FAQ Contact Login → Login → Uncover Drug Assets 10x faster Find and evaluate drugs better than ever before. Test the Agents Free to try. No credit card. Overview How Convexia Works…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗AI-driven drug sourcing and diligence for pharma.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗3 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Agents surface shelved and overlooked preclinical assets.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
Summer 2025 batch; AI-maximalist pharma sourcing and diligence.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.